Dianthus Therapeutics, Inc. /DE/ (DNTH) Income Tax Expense (Benefit) USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Dianthus Therapeutics, Inc. /DE/ annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
  • Dianthus Therapeutics, Inc. /DE/ Income Tax Expense (Benefit) for the quarter ending September 30, 2018 was $0.000.
  • Dianthus Therapeutics, Inc. /DE/ annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Dianthus Therapeutics, Inc. /DE/ annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Dianthus Therapeutics, Inc. /DE/ annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 8-K 2023-12-21
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-03-03
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-03-03
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.